Back to Results

Sona Nanotech Inc (SNANF)

Sona Nanotech Inc. is a common stock listing on OTC Markets tied to a healthcare company focused on nanotechnology and life sciences. The company develops gold nanoparticle-based technologies in the United States and Canada for potential use in therapy and diagnostics. Its research work includes applications such as photothermal therapy, tumor targeting, antibacterial uses, and drug delivery, along with diagnostic tools for imaging, immunoassay, and biosensing. Sona Nanotech also works on targeted hyperthermia therapy for cancer tumors and on diagnostic products such as lateral flow assay rapid tests and bovine tuberculosis tests. Founded in 2013, the company is based in Halifax, Canada.


Stock Summary Fair Value Profitability & Growth Quality & Risk Events & Dividends Market Outlook FAQ

Jump directly to the stock analysis sections supported by the latest available data.

Data update note: Fair value and stock analysis metrics are updated after regular market sessions when new data becomes available.
Ticker Fair Value Fair Value Upside/Downside Fair Value Rating Analyst Price Target Analyst Target Upside/Downside Overall Financial Health Dividend Yield Next Earnings Date Market Cap Enterprise Value Total Debt / Total Capital Free Float / Shares Outstanding Altman Z-Score Free Cash Flow / Net Income
OTC-SNAN.F
$0.18
-29.7% Downside
Overvalued
Not available
Not available
Fair
0.0%
September 24, 2026
32.739 M
32.296 M
0.8%
85.3%
-1,332.9
46.0%
Valuation • Fair Value

Sona Nanotech Inc (OTC-SNAN.F) Fair Value by Valuation Model

Review the available estimates for Sona Nanotech Inc (OTC-SNAN.F), including Comps Fair Value.

Primary Valuation Read

Fair Value

$0.18

Estimated downside of 29.7% versus the current market price.

Fair Value Confidence

Low

Confidence level for the primary fair value estimate.

Comps Fair Value

$0.18

Comparable-company valuation reference.

Analyst Price Target

Not available

Data is currently unavailable.

How to read these valuation models

Use the 3 available valuation references for Sona Nanotech Inc (OTC-SNAN.F) as analytical inputs, not a standalone conclusion. Valuation methods can differ because they rely on different assumptions, time horizons and financial inputs; compare the estimates with the current price and the company’s financial quality.

Profitability • Growth

Profitability & Growth for Sona Nanotech Inc (OTC-SNAN.F)

Review the profitability and growth indicators currently supported by the latest data.

Revenue Forecast

0 K

Forward revenue estimate.

EBITDA

-1.562 M

Current operating profitability reference.

How to read profitability and growth

This section helps investors review Sona Nanotech Inc (OTC-SNAN.F) from an operating perspective by combining current scale, forward revenue expectations and EBITDA-related profitability measures.

Quality • Risk

Quality & Financial Risk for Sona Nanotech Inc (OTC-SNAN.F)

Review the financial quality and risk indicators currently supported by the latest data.

Financial Health

Fair

Mixed or neutral financial-health read.

Piotroski Score

1

Weak quality score that deserves closer review.

Altman Z-Score

-1,332.9

Lower score that deserves closer risk review.

FCF / Net Income

46.0%

Cash conversion quality indicator.

How to read quality and risk

This section combines quality, balance-sheet and accounting-risk indicators for Sona Nanotech Inc (OTC-SNAN.F). Read the metrics together: no single score is a complete investment conclusion, but the combined view can highlight financial strength, earnings quality and areas that may deserve closer review.

Events • Dividends

Upcoming Events & Dividends for Sona Nanotech Inc (OTC-SNAN.F)

Track the upcoming dates and dividend metrics currently supported by the latest data.

Next Earnings Date

September 24, 2026

Days to Earnings

2

Dividend Yield

0.0%

No current dividend yield is indicated.

How to read events and dividends

This section helps investors track time-sensitive items for Sona Nanotech Inc (OTC-SNAN.F), including the next earnings date and dividend-related milestones. These items can matter for short-term volatility, income planning and event-driven positioning.

Technical Outlook

Technical Signals by Time Frame

Review the technical signals currently available for this stock across supported time frames.

Technical Signals by Time Frame

Switch between time frames to review the current technical signal for the stock.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: 15-minute • intraday
Strong Buy

The 15-minute technical read for Sona Nanotech Inc (OTC-SNAN.F) is currently Strong Buy. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: 1-hour • short-term
Strong Buy

The 1-hour technical read for Sona Nanotech Inc (OTC-SNAN.F) is currently Strong Buy. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: daily • daily
Strong Buy

The daily technical read for Sona Nanotech Inc (OTC-SNAN.F) is currently Strong Buy. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: weekly • weekly
Strong Buy

The weekly technical read for Sona Nanotech Inc (OTC-SNAN.F) is currently Strong Buy. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: monthly • monthly
Strong Sell

The monthly technical read for Sona Nanotech Inc (OTC-SNAN.F) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

FAQ • Fast Investor Answers

Sona Nanotech Inc (OTC-SNAN.F) Stock FAQ

Data-supported answers about Sona Nanotech Inc (OTC-SNAN.F), including explicit coverage status where a reliable valuation estimate is not currently available.

Fair Value
$0.18
Estimated downside 29.7%
Valuation Rating
Overvalued
Estimated downside of 29.7%
Financial Health
Fair
Current financial-health read

The current fair value estimate for Sona Nanotech Inc (OTC-SNAN.F) is $0.18. This implies an estimated downside of 29.7% versus the current market price.

Based on the current fair value estimate, the stock appears overvalued, with estimated downside of 29.7% versus the current market price.

The current financial health read for Sona Nanotech Inc (OTC-SNAN.F) is Fair. This should be reviewed alongside valuation, profitability, debt and cash-flow quality metrics.

The next earnings date currently listed for Sona Nanotech Inc (OTC-SNAN.F) is September 24, 2026.

The latest available data indicates no current dividend yield for Sona Nanotech Inc (OTC-SNAN.F).

The current market capitalization listed for Sona Nanotech Inc is 32.739 M.

The current enterprise value listed for Sona Nanotech Inc is 32.296 M. Enterprise value can provide a broader valuation view than market capitalization alone because it also considers net debt.

The ticker symbol for Sona Nanotech Inc is OTC-SNAN.F, and the stock is listed on OTC Markets.

Sona Nanotech Inc (OTC-SNAN.F) is listed on OTC Markets.

The current debt-to-total-capital ratio listed for Sona Nanotech Inc is 0.8%, which helps investors evaluate the company’s financing structure and leverage profile.

The free float listed for Sona Nanotech Inc is 85.3%. Free float helps investors understand how much of the share base is available for public trading.

Similar Life Sciences Tools & Services Stocks View more on OTC Markets

Comparable companies from the same industry, limited to one security per issuer.

TMO NYSE Thermo Fisher Scientific Inc Fair Value Fair Market Cap 243.5 B
DHR NYSE Danaher Corporation Fair Value Fair Market Cap 155.4 B
A NYSE Agilent Technologies Inc Fair Value Fair Market Cap 47.155 B
IQV NYSE IQVIA Holdings Inc Fair Value Fair Market Cap 44.457 B
WAT NYSE Waters Corporation Fair Value Overvalued Market Cap 41.828 B
ILMN NASDAQ Illumina Inc Fair Value Overvalued Market Cap 37.366 B
MTD NYSE Mettler-Toledo International Inc Fair Value Fair Market Cap 29.87 B
WST NYSE West Pharmaceutical Services Inc Fair Value Fair Market Cap 26.116 B
MEDP NASDAQ Medpace Holdings Inc Fair Value Fair Market Cap 17.59 B
RVTY NYSE Revvity Inc Fair Value Fair Market Cap 15.991 B
TEM NASDAQ Tempus AI Inc Fair Value Overvalued Market Cap 13.928 B
CRL NYSE Charles River Laboratories Fair Value Fair Market Cap 13.611 B
ICLR NASDAQ ICON PLC Fair Value Fair Market Cap 12.894 B
TECH NASDAQ Bio-Techne Corp Fair Value Fair Market Cap 11.377 B
RGEN NASDAQ Repligen Corporation Fair Value Overvalued Market Cap 10.539 B
TXG NASDAQ 10X Genomics Inc Fair Value Overvalued Market Cap 10.514 B
AVTR NYSE Avantor Inc Fair Value Fair Market Cap 10.105 B
BIOB NYSE Bio-Rad Laboratories B Fair Value Fair Market Cap 10.076 B
BIO NYSE Bio-Rad Laboratories Inc Fair Value Fair Market Cap 10.076 B
BRKR NASDAQ Bruker Corporation Fair Value Fair Market Cap 9.326 B